Gluconeogenesis: Your liver is making glucose while you sleep. Here’s why that’s both normal and, sometimes, a problem.
The dawn phenomenon, gluconeogenesis, and what your fasting blood sugar is actually telling you.
You wake up. You haven’t eaten in ten hours. You’re basically running on fumes and spite. So why does your blood glucose read higher than when you went to bed?
Welcome to gluconeogenesis — your liver’s overnight side hustle — and its sometimes-inconvenient consequence, the dawn phenomenon. Understanding what’s happening during those quiet pre-sunrise hours is increasingly relevant not just for people managing diabetes, but for anyone using a continuous glucose monitor (CGM), optimizing metabolic health, or simply curious why “fasting” glucose numbers don’t always behave the way you’d expect.
Gluconeogenesis: Your Liver’s 3 a.m. Shift
The word sounds like it should be on a Marvel villain’s business card, but gluconeogenesis is actually one of the more elegant survival mechanisms in human biology. It’s the process by which your liver (and, to a lesser extent, your kidneys) manufactures glucose from non-carbohydrate precursors — primarily amino acids, lactate, and glycerol. No carbs? No problem. Your liver will build glucose from scratch.
This matters enormously. Your brain runs almost exclusively on glucose and, unlike muscle, can’t switch to fat for fuel on short notice. So during sleep — an extended fast, by any other name — your liver serves as the overnight glucose vending machine, keeping plasma glucose stable somewhere in the 70–100 mg/dL range while your conscious mind is busy narrating unhinged dream sequences.
There are actually two hepatic levers at work here:
- Glycogenolysis: Breaking down stored glycogen into glucose. Think of this as drawing from a checking account.
- Gluconeogenesis: Building new glucose from scratch. This is the savings account — slower to access, but essentially unlimited as long as substrates are available.
Early in an overnight fast, glycogen breakdown does the heavy lifting. As the night stretches on, gluconeogenesis takes over. By early morning, the liver is actively manufacturing glucose — and, crucially, it gets a hormonal push to do so.
Enter the Dawn Patrol: Growth Hormone, Cortisol, and Friends
Between roughly 2 a.m. and 8 a.m., your body stages what endocrinologists politely call a “counter-regulatory hormone surge.” Growth hormone spikes during deep sleep. Cortisol begins its characteristic morning ramp-up. Catecholamines edge upward. These hormones all share a common metabolic agenda: tell the liver to make more glucose.
Growth hormone and catecholamines lead to increased rates of glucose production and release from the liver and also inhibit the effects of insulin, leading to an overall increase in circulating blood glucose.
The dawn phenomenon — first formally described by Dr. Michael Schmidt in 1981 — is the clinical name for the resulting early-morning glucose rise. It is often defined as an increase in blood glucose of at least 20 mg/dL (1.1 mmol/L) between the lowest nocturnal level and the highest pre-breakfast reading.
Here’s the thing though: this is completely normal. In people without diabetes, plasma insulin tends to remain stable and consistent during the night, with a slight, transient increase in insulin secretion just before dawn. This increase in insulin suppresses hepatic glucose production, thereby preventing hyperglycemia. Your pancreas quietly cleans up the mess. You never notice. Your CGM barely twitches.
Cortisol and growth hormone rise during the night, especially toward the morning — “This is normal and happens in everyone, and for most people, the body takes care of it,” as Dr. Marc-André Cornier of the Medical University of South Carolina has noted.
The problem emerges when the cleanup crew doesn’t show up on time.
When the Cleanup Crew Ghosts You
In type 1 diabetes, the pancreas produces little to no insulin, so there’s no pre-dawn insulin surge to blunt hepatic glucose output. In type 2 diabetes, a combination of insulin resistance and impaired beta-cell function means the compensatory response is either too weak or too slow.
The early morning transient hyperglycemia appears to be due to an increase in glycogenolysis and gluconeogenesis associated with inadequate insulin secretion, sub-optimal insulin action, or insulin resistance. The excess hepatic glucose production appears to be a consequence of the unopposed action of growth hormone and other counter-regulatory hormones.
The clinical consequences aren’t trivial. The dawn phenomenon has been reported in more than 50% of adults with type 2 diabetes, contributing to an average rise of 0.4% in HbA1c levels. That’s not noise — that’s a meaningful chunk of your A1c attributable entirely to what your liver does before breakfast.
There’s also an “extended” version. The extended dawn phenomenon refers to the persistence of hepatic glucose overproduction not encountered in non-diabetic subjects, compounded by intestinal hydrolysis of carbohydrates following breakfast. In other words, some people get a double hit: the pre-breakfast glucose surge, then an exaggerated post-breakfast spike on top of it. Your glucose monitor has strong feelings about this.
Dawn Phenomenon vs. Somogyi Effect: Don’t Mix These Up
There’s a conceptual lookalike in this space worth distinguishing. The Somogyi effect (or Somogyi phenomenon) proposes that early-morning hyperglycemia is actually a rebound from nocturnal hypoglycemia — your body overcompensating for a low overnight blood sugar by flooding the system with counter-regulatory hormones.
The dawn phenomenon, by contrast, doesn’t require any prior low. It happens on its own, driven by circadian hormone patterns.
The dawn phenomenon differs from the Somogyi effect in that it is not preceded by an episode of hypoglycemia.
The clinical relevance: if you’re adjusting insulin because your fasting glucose is high, you need to know why it’s high. Increasing your overnight insulin dose to treat dawn phenomenon is appropriate. Doing the same when the cause is actually rebound hypoglycemia could make things considerably worse. A CGM showing no overnight lows points toward dawn phenomenon. A dip below 70 mg/dL at 2–3 a.m. followed by a morning rebound is more consistent with Somogyi — though the latter is considered probably rare in clinical practice.
Gluconeogenesis: Who Should Actually Care About This?
People with type 1 or type 2 diabetes
The clearest clinical concern. The dawn phenomenon has been documented in both type 1 and type 2 diabetes across all age groups, and its prevalence is estimated to exceed 50 percent for both. This is not a niche presentation.
People with prediabetes or metabolic syndrome
The dawn phenomenon is evident when HbA1c levels range from 5.7 to 6.4%, suggesting it may actually precede the full diagnosis of type 2 diabetes. If you’re in that gray zone and wondering why your fasting glucose is stubbornly elevated while your post-meal numbers look fine, the dawn phenomenon may be introducing itself.
CGM users generally
The explosion of consumer CGM use has brought the dawn phenomenon to a much wider audience. Plenty of metabolically healthy people are now watching their glucose tick upward around 4–5 a.m. and having mild existential crises about it. For most of these people, the rise is modest (under 20 mg/dL), gets blunted by endogenous insulin, and requires no intervention beyond understanding what they’re looking at.
Anyone who fasts in the morning
If you practice intermittent fasting or skip breakfast, you may be extending the window during which gluconeogenesis is running unopposed. In a healthy person, that’s not a problem — glucose production simply comes back into balance when you eat. But it does explain why “fasting” blood glucose can sometimes be higher after a long overnight fast than after a shorter one, which confuses many first-time CGM adopters.
Gluconeogenesis: What Actually Helps
Let’s be direct: for people without diabetes and with normal insulin sensitivity, the dawn phenomenon is a background metabolic event that requires no intervention. Your body handles it. Move along.
For people with diabetes or clinically concerning fasting glucose elevation, the evidence-based toolkit looks like this:
Dietary timing
Research suggests that a higher protein-to-carbohydrate ratio during the evening meal can decrease the secretion of insulin-antagonistic hormones. Eating a large dinner late at night means going to bed with already elevated glucose levels and will accentuate the dawn phenomenon, while eating a smaller meal earlier in the evening allows the natural morning rise to begin from a lower baseline. Earlier dinner windows also have general metabolic benefits that align nicely with this.
Breakfast composition
Breakfast content is important — a lower-carbohydrate, lower-sugar breakfast is generally recommended in those with the dawn phenomenon, given that insulin sensitivity is at its daily low in the early morning. Loading up on glucose right when your liver is in peak glucose-production mode is a particularly bad look from a metabolic standpoint.
Evening exercise
Regular physical activity, particularly in the late afternoon or evening, improves insulin sensitivity and can help blunt the magnitude of overnight glucose rises. This doesn’t need to be intense — a 20-minute walk after dinner has meaningful effects on overnight glucose patterns.
Metformin timing
For patients already on metformin, taking the dose at night rather than in the morning targets hepatic glucose production more directly during the hours when it’s most active. Metformin’s primary mechanism — suppression of gluconeogenesis — makes it particularly well-matched to this specific problem.
Basal insulin optimization
For insulin-dependent patients, adjusting the timing and formulation of basal insulin to provide more coverage in the pre-dawn window is often the most effective pharmacological approach. Insulin pumps can be programmed to automatically increase basal delivery between 3–7 a.m., which is about as targeted as it gets.
Sleep
This one is easy to overlook. Disruptions to circadian rhythms, such as irregular sleep patterns or shift work, can exacerbate the dawn phenomenon. Protecting sleep quality and consistency isn’t just general health advice — it directly regulates the hormone cascade that drives morning glucose elevation.
Gluconeogenesis: The Bottom Line
Gluconeogenesis is not a bug. It is a feature — one that kept our ancestors alive during the long mammalian experiment of sleeping without a refrigerator nearby. The dawn phenomenon is the predictable consequence of this system operating in a high-hormone morning environment.
In healthy people, the pancreas quietly neutralizes it before breakfast. In people with impaired insulin response, it creates a real and persistent clinical problem that contributes meaningfully to HbA1c and long-term glycemic control.
If your CGM shows a gentle pre-dawn rise that self-corrects by mid-morning, you’re watching normal physiology. If it shows persistent, high fasting values that bleed into the postprandial period and won’t budge — that’s your metabolic canary and worth taking seriously.
As always: watch the trend, not the number. A single fasting glucose means almost nothing in isolation. Context is everything, and your liver, it turns out, has been very busy while you were dreaming.
